The 29 references in paper N. Ryazantseva V., E. Kaygorodova V., M. Belkina V., A. Maroshkina N., O. Chechina E., A. Zima P., V. Novitskii V., Н. Рязанцева В., Е. Кайгородова В., М. Белкина В., А. Марошкина Н., О. Чечина Е., А. Зима П., В. Новицкий В. (2014) “СУПЕРСЕМЕЙСТВО РЕЦЕПТОРА ФАКТОРА НЕКРОЗА ОПУХОЛИ Α И БЕЛОК ТЕПЛОВОГО ШОКА HSP90: МОЛЕКУЛЯРНЫЕ ОСНОВЫ ВЗАИМООТНОШЕНИЯ // RECEPTOR SUPERFAMILY OF TUMOR NECROSIS FACTOR Α, AND HSP90 HEAT SHOCK PROTEIN: A MOLECULAR BASIS FOR INTERACTIONS” / spz:neicon:mimmun:y:2011:i:3:p:247-252

1
Жижина Г.П. Роль апоптоза в нормальном онтогенезе, патогенезе и старении // Клиническая геронтология. – 2002. – Т. 8, No 4. – С. 3-10.
(check this in PDF content)
2
Жукова О.Б., Рязанцева Н.В., Новицкий В.В. Апоптоз и вирусная инфекция. – Томск: Изд-во Том. ун-та, 2006. – 142 с.
(check this in PDF content)
3
Кайгородова Е.В., Рязанцева Н.В., Новицкий В.В., Марошкина А.Н., Белкина М.В., Чечина О.Е., Зима А.П. Действие ингибиторов белков теплового шока 90 и 27 на дексаметазониндуцированный апоптоз опухолевых клеток // Бюллетень сибирской медицины. – 2010. – No 3. – C. 68-72.
(check this in PDF content)
4
Кайгородова Е.В., Рязанцева Н.В., Новицкий В.В. , Белкина М.В. , Марошкина А.Н. Роль белка теплового шока 90 в регуляции апоптоза опухолевых клеток // Бюллетень экспериментальной биологии и медицины. – 2010. – Т. 150, No 10. – С. 424-427.
(check this in PDF content)
5
Кетлинский С.А., Симбирцев А.С. Цитокины. – СПб: Фолиант, 2008. – 552 с.
(check this in PDF content)
6
Косенков Д.А., Ляшенко А.А., Кешелава В.В., Северин Е.С. Основные виды противоопухолевых вакцин // Вопросы биологической медицинской и фармацевтической химии. – 2007. – No 3. – C. 3-9.
(check this in PDF content)
7
Рязанцева Н.В., Новицкий В.В., Жукова О.Б. Роль NF-κB, p53 и p21 в регуляции ФНОαопосредованного апоптоза лимфоцитов // Бюллетень экспериментальной биологии и медицины. – 2010. – Т. 149, No 1. – С. 56-59.
(check this in PDF content)
8
Фильченков А.А. Апоптомодуляторы // Биомедицинская химия. – 2003. – Т. 49, No 4. – С. 333-359.
(check this in PDF content)
9
Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors // Cytokine Growth Factor Rev. – 1996. – Vol. 7, N 3. – P. 231-240.
(check this in PDF content)
10
Amolins M.W., Blagg B.S. Natural product inhibitors of Hsp90: potential leads for drug discovery // Mini Rev. Med. Chem. – 2009. – Vol. 9, N 2. – P. 140-52.
(check this in PDF content)
11
Arya R., Mallik M., Lakhotia S.C. Heat shock genes – integrating cell survival and death // J. Biosci. – 2007. – Vol. 32, N 3. – P. 595-610.
(check this in PDF content)
12
Becker B., Multhoff G., Farkas B., Wild P.J., Landthaler M., Stolz W., Vogt T. Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases // Exp. Dermatol. – 2004. – Vol. 13, N 1. – P. 27-32.
(check this in PDF content)
13
Beere H.M. Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways // J. Clin. Invest. – 2005. – Vol. 115, N 10. – P. 2633-2639.
(check this in PDF content)
14
Bradley J.R. TNF-mediated inflammatory disease // J. Pathol. – 2008. – Vol. 214, N 2. – P. 149160.
(check this in PDF content)
15
Chen G., Cao P., Goeddel D.V. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90 // Mol. Cell. – 2002. – Vol. 9, N 2. – P. 401-410.
(check this in PDF content)
16
Gallegos Ruiz M.I., Floor K., Roepman P., Rodriguez J.A., Meijer G.A., Mooi W.J., Jassem E., Niklinski J., Muley T., van Zandwijk N., Smit E.F., Beebe K., Neckers L., Ylstra B., Giaccone G. Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target // PLoS One. – 2008. – Vol. 3, Issue 3. – P. 1-8.
(check this in PDF content)
17
Hartl F.U., Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein // Science. – 2002. – Vol. 295, N 5561. – P. 1852-1858.
(check this in PDF content)
18
Hehlgans T., Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games // Immunology. – 2005. – Vol. 115, N 1. – P. 1-20.
(check this in PDF content)
19
Hirata H., Takahashi A., Kobayashi S., Yonehara S., Sawai H., Okazaki T., Yamamoto K., Sasada M. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis // J. Exp. Med. – 1998. – Vol. 187, N 4. – P. 587-600.
(check this in PDF content)
20
Lanneau D., Brunet M., Frisan E., Solary E., Fontenay M., Garrido C. Heat shock proteins: essential proteins for apoptosis regulation // J. Cell. Mol. Med. – 2008. – Vol. 12, N 3. – Р. 743-761.
(check this in PDF content)
21
Lejeune F. J., Linard D., Matter M., Regg C. Efficiency of recombinant human TNF in human cancer therapy // Cancer Immunity. – 2006. – Vol. 6. – P. 6-22.
(check this in PDF content)
22
Lewis J., Devin A., Miller A., Lin Y., Rodriguez Y., Neckers L., Liu Z.-G. Disruption of Hsp90 Function Results in Degradation of the Death Domain Kinase, Receptor-interacting Protein (RIP), and Blockage of Tumor Necrosis Factor-induced Nuclear Factor-κB Activation // J. Biol. Chem. – 2000. – Vol. 275, N 14. – P. 10519-10526.
(check this in PDF content)
23
Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology // Cell. – 2001. – Vol. 104, N 4. – P. 487-501.
(check this in PDF content)
24
Micheau O., Solary E., Hammann A., Dimanche-Boitrel M.T. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs // J. Biol. Chem. – 1999. – Vol. 274, N 12. – P. 7987-7992.
(check this in PDF content)
25
Ogata M., Naito Z., Tanaka S., Moriyama Y., Asano G. Overexpression and localization of heat shock proteins mRNA in pancreatic carcinoma // J. Nippon Med. Sch. – 2000. – Vol. 67, N 3. – P. 177185.
(check this in PDF content)
26
Screaton G., Xu X.N. T cell life and death signaling via TNF-receptor family members // Curr. Opin. Immunol. – 2000. – Vol. 12, N 3. – P. 316-322.
(check this in PDF content)
27
Smyth M.J., Cretney E., Kelly J.M., Westwood J.A., Street S.E., Yagita H., Takeda K., van Dommelen S.L., Degli-Esposti M.A., Hayakawa Y. Activation of NK cell cytotoxicity // Mol. Immunol. – 2005. – Vol. 42, N 4. – P. 501-510.
(check this in PDF content)
28
Wang X., Lin Y. Tumor necrosis factor and cancer, buddies or foes? // Acta Pharmacol Sin. – 2008. – Vol. 29, N 11. – P. 1275-1288.
(check this in PDF content)
29
Zhang G. Tumor necrosis factor family ligandreceptor binding // Curr. Opin. Struct. Biol. – 2004. – Vol. 14, N 2. – P. 154-160. поступила в редакцию 08.02.2011 принята к печати 12.02.2011
(check this in PDF content)